MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Finance & Acquisition: Bay City
*Portfolio Companies: Bay City
Perlegen Sciences
Parents
*Portfolio Companies: Bay City
Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Architects: Biotechnology _ Life Science Bioinformatics, Bioanalysis
Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Portfolio Companies: SB Life Science
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
Children
Perlegen also applies this expertise to discovering genetic variants associated with disease for potential new therapeutics and
Pharmaceutical partners to associate genetic haplotypes with health and drug response.
Provide safe and effective personalized medicines
Scanning DNA of thousands of individuals
The company analyzes millions of unique genetic variations in DNA samples
The company has in-licensed a clinical-stage diabetes/metabolic syndrome product and is applying its technology to develop the d
Uses the information to explain and predict the efficacy and adverse effects of prescription drugs.